EMEA Cancer Treatment Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2022

October 2017 | 120 pages | ID: E748682B0AAEN
GlobalInfoResearch

Abstracts

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

Scope of the Report:

This report focuses on the Cancer Treatment Drugs in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

• Roche
• Novartis
• Celgene
• Amgen
• Johnson & Johnson
• Bristol-Myers Squibb
• Takeda
• Eli Lilly
• Pfizer
• AstraZeneca
• Astellas
• Sanofi
• Bayer
• Merck & Co.
• Biogen Idec
• Kyowa Hakko Kirin
• Otsuka
• Teva
• Eisai
• Merck KGaA
• Ipsen
• AbbVie
• Gilead Sciences

Market Segment by Regions, regional analysis covers

• Europe (Germany, France, UK, Russia, Italy and Turkey)
• Middle East (Saudi Arabia, Israel, UAE and Iran)
• Africa (South Africa, Nigeria, Egypt and Algeria)

Market Segment by Type, covers

• Chemotherapy
• Targeted Therapy
• Immunotherapy (Biologic Therapy)
• Hormonal Therapy
• Others

Market Segment by Applications, can be divided into

• Blood Cancer
• Breast Cancer
• Gastrointestinal Cancer
• Prostate Cancer
• Respiratory/Lung Cancer
• Other Cancers

There are 13 Chapters to deeply display the EMEA Cancer Treatment Drugs market.

Chapter 1, to describe Cancer Treatment Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Cancer Treatment Drugs, with sales, revenue, and price of Cancer Treatment Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Cancer Treatment Drugs, for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, Cancer Treatment Drugs market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe Cancer Treatment Drugs research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Cancer Treatment Drugs Introduction
1.2 Market Analysis by Type
  1.2.1 Chemotherapy
  1.2.2 Targeted Therapy
  1.2.3 Immunotherapy (Biologic Therapy)
  1.2.4 Hormonal Therapy
  1.2.5 Others
1.3 Market Analysis by Applications
  1.3.1 Blood Cancer
  1.3.2 Breast Cancer
  1.3.3 Gastrointestinal Cancer
  1.3.4 Prostate Cancer
  1.3.5 Respiratory/Lung Cancer
  1.3.6 Other Cancers
1.4 Market Analysis by Regions
  1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
    1.4.1.1 Germany Market States and Outlook (2012-2022)
    1.4.1.2 France Market States and Outlook (2012-2022)
    1.4.1.3 UK Market States and Outlook (2012-2022)
    1.4.1.4 Italy Market States and Outlook (2012-2022)
    1.4.1.5 Russia Market States and Outlook (2012-2022)
    1.4.1.6 Turkey Market States and Outlook (2012-2022)
  1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
    1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022)
    1.4.2.2 UAE Market States and Outlook (2012-2022)
    1.4.2.3 Israel Market States and Outlook (2012-2022)
    1.4.2.4 Iran Market States and Outlook (2012-2022)
  1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
    1.4.3.1 South Africa Market States and Outlook (2012-2022)
    1.4.3.2 Nigeria Market States and Outlook (2012-2022)
    1.4.3.3 Egypt Market States and Outlook (2012-2022)
    1.4.3.4 Algeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Roche
  2.1.1 Business Overview
  2.1.2 Cancer Treatment Drugs Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
  2.2.1 Business Overview
  2.2.2 Cancer Treatment Drugs Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Celgene
  2.3.1 Business Overview
  2.3.2 Cancer Treatment Drugs Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Amgen
  2.4.1 Business Overview
  2.4.2 Cancer Treatment Drugs Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson & Johnson
  2.5.1 Business Overview
  2.5.2 Cancer Treatment Drugs Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bristol-Myers Squibb
  2.6.1 Business Overview
  2.6.2 Cancer Treatment Drugs Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Takeda
  2.7.1 Business Overview
  2.7.2 Cancer Treatment Drugs Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Eli Lilly
  2.8.1 Business Overview
  2.8.2 Cancer Treatment Drugs Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer
  2.9.1 Business Overview
  2.9.2 Cancer Treatment Drugs Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AstraZeneca
  2.10.1 Business Overview
  2.10.2 Cancer Treatment Drugs Type and Applications
    2.10.2.1 Type
    2.10.2.2 Type
  2.10.3 AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Astellas
  2.11.1 Business Overview
  2.11.2 Cancer Treatment Drugs Type and Applications
    2.11.2.1 Type
    2.11.2.2 Type
  2.11.3 Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Sanofi
  2.12.1 Business Overview
  2.12.2 Cancer Treatment Drugs Type and Applications
    2.12.2.1 Type
    2.12.2.2 Type
  2.12.3 Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Bayer
  2.13.1 Business Overview
  2.13.2 Cancer Treatment Drugs Type and Applications
    2.13.2.1 Type
    2.13.2.2 Type
  2.13.3 Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Merck & Co.
  2.14.1 Business Overview
  2.14.2 Cancer Treatment Drugs Type and Applications
    2.14.2.1 Type
    2.14.2.2 Type
  2.14.3 Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Biogen Idec
  2.15.1 Business Overview
  2.15.2 Cancer Treatment Drugs Type and Applications
    2.15.2.1 Type
    2.15.2.2 Type
  2.15.3 Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Kyowa Hakko Kirin
  2.16.1 Business Overview
  2.16.2 Cancer Treatment Drugs Type and Applications
    2.16.2.1 Type
    2.16.2.2 Type
  2.16.3 Kyowa Hakko Kirin Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Otsuka
  2.17.1 Business Overview
  2.17.2 Cancer Treatment Drugs Type and Applications
    2.17.2.1 Type
    2.17.2.2 Type
  2.17.3 Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Teva
  2.18.1 Business Overview
  2.18.2 Cancer Treatment Drugs Type and Applications
    2.18.2.1 Type
    2.18.2.2 Type
  2.18.3 Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Eisai
  2.19.1 Business Overview
  2.19.2 Cancer Treatment Drugs Type and Applications
    2.19.2.1 Type
    2.19.2.2 Type
  2.19.3 Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Merck KGaA
  2.20.1 Business Overview
  2.20.2 Cancer Treatment Drugs Type and Applications
    2.20.2.1 Type
    2.20.2.2 Type
  2.20.3 Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Ipsen
  2.21.1 Business Overview
  2.2.2 Cancer Treatment Drugs Type and Applications
    2.21.2.1 Type
    2.21.2.2 Type
  2.21.3 Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22 AbbVie
  2.22.1 Business Overview
  2.22.2 Cancer Treatment Drugs Type and Applications
    2.22.2.1 Type
    2.22.2.2 Type
  2.22.3 AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.23 Gilead Sciences
  2.23.1 Business Overview
  2.23.2 Cancer Treatment Drugs Type and Applications
    2.23.2.1 Type
    2.23.2.2 Type
  2.23.3 Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 EMEA CANCER TREATMENT DRUGS MARKET COMPETITION, BY MANUFACTURER

3.1 EMEA Cancer Treatment Drugs Sales and Market Share by Manufacturer
3.2 EMEA Cancer Treatment Drugs Revenue and Market Share by Manufacturer
3.3 EMEA Cancer Treatment Drugs Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Cancer Treatment Drugs Manufacturer Market Share
  3.4.2 Top 5 Cancer Treatment Drugs Manufacturer Market Share
3.5 Market Competition Trend

4 EMEA CANCER TREATMENT DRUGS MARKET ANALYSIS BY REGIONS

4.1 EMEA Cancer Treatment Drugs Sales, Revenue and Market Share by Regions
  4.1.1 EMEA Cancer Treatment Drugs Sales by Regions (2012-2017)
  4.1.2 EMEA Cancer Treatment Drugs Revenue by Regions (2012-2017)
4.2 Europe Cancer Treatment Drugs Sales and Growth (2012-2017)
4.3 Middle East Cancer Treatment Drugs Sales and Growth (2012-2017)
4.4 Africa Cancer Treatment Drugs Sales and Growth (2012-2017)

5 EUROPE CANCER TREATMENT DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 Europe Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
  5.1.1 Europe Cancer Treatment Drugs Sales by Countries (2012-2017)
  5.1.2 Europe Cancer Treatment Drugs Revenue by Countries (2012-2017)
  5.1.3 Germany Cancer Treatment Drugs Sales and Growth (2012-2017)
  5.1.4 France Cancer Treatment Drugs Sales and Growth (2012-2017)
  5.1.5 UK Cancer Treatment Drugs Sales and Growth (2012-2017)
  5.1.6 Russia Cancer Treatment Drugs Sales and Growth (2012-2017)
  5.1.7 Italy Cancer Treatment Drugs Sales and Growth (2012-2017)
  5.1.8 Turkey Cancer Treatment Drugs Sales and Growth (2012-2017)
5.2 Europe Cancer Treatment Drugs Sales and Revenue (value) by Manufacturers (2016-2017)
  5.2.1 Europe Cancer Treatment Drugs Sales by Manufacturers (2016-2017)
  5.2.2 Europe Cancer Treatment Drugs Revenue by Manufacturers (2016-2017)
5.3 Europe Cancer Treatment Drugs Sales by Type (2012-2017)
5.4 Europe Cancer Treatment Drugs Sales by Application (2012-2017)

6 MIDDLE EAST CANCER TREATMENT DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Middle East Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
  6.1.1 Middle East Cancer Treatment Drugs Sales by Countries (2012-2017)
  6.1.2 Middle East Cancer Treatment Drugs Revenue by Countries (2012-2017)
  6.1.3 Saudi Arabia Cancer Treatment Drugs Sales and Growth (2012-2017)
  6.1.4 Israel Cancer Treatment Drugs Sales and Growth (2012-2017)
  6.1.5 UAE Cancer Treatment Drugs Sales and Growth (2012-2017)
  6.1.6 Iran Cancer Treatment Drugs Sales and Growth (2012-2017)
6.2 Middle East Cancer Treatment Drugs Sales and Revenue (value) by Manufacturers (2016-2017)
  6.2.1 Middle East Cancer Treatment Drugs Sales by Manufacturers (2016-2017)
  6.2.2 Middle East Cancer Treatment Drugs Revenue by Manufacturers (2016-2017)
6.3 Middle East Cancer Treatment Drugs Sales by Type (2012-2017)
6.4 Middle East Cancer Treatment Drugs Sales by Application (2012-2017)

7 AFRICA CANCER TREATMENT DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Africa Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
  7.1.1 Africa Cancer Treatment Drugs Sales by Countries (2012-2017)
  7.1.2 Africa Cancer Treatment Drugs Revenue by Countries (2012-2017)
  7.1.3 South Africa Cancer Treatment Drugs Sales and Growth (2012-2017)
  7.1.4 Nigeria Cancer Treatment Drugs Sales and Growth (2012-2017)
  7.1.5 Egypt Cancer Treatment Drugs Sales and Growth (2012-2017)
  7.1.6 Algeria Cancer Treatment Drugs Sales and Growth (2012-2017)
7.2 Middle East Cancer Treatment Drugs Sales and Revenue (value) by Manufacturers (2016-2017)
  7.2.1 Middle East Cancer Treatment Drugs Sales by Manufacturers (2016-2017)
  7.2.2 Middle East Cancer Treatment Drugs Revenue by Manufacturers (2016-2017)
7.3 Middle East Cancer Treatment Drugs Sales by Type (2012-2017)
7.4 Middle East Cancer Treatment Drugs Sales by Application (2012-2017)

8 EMEA CANCER TREATMENT DRUGS MARKET SEGMENT BY TYPE

8.1 EMEA Cancer Treatment Drugs Sales, Revenue and Market Share by Type (2012-2017)
  8.1.1 EMEA Cancer Treatment Drugs Sales and Market Share by Type (2012-2017)
  8.1.2 EMEA Cancer Treatment Drugs Revenue and Market Share by Type (2012-2017)
8.2 Chemotherapy Sales Growth and Price
  10.2.1 EMEA Chemotherapy Sales Growth (2012-2017)
  10.2.2 EMEA Chemotherapy Price (2012-2017)
8.3 Targeted Therapy Sales Growth and Price
  10.3.1 EMEA Targeted Therapy Sales Growth (2012-2017)
  10.3.2 EMEA Targeted Therapy Price (2012-2017)
8.4 Immunotherapy (Biologic Therapy) Sales Growth and Price
  10.4.1 EMEA Immunotherapy (Biologic Therapy) Sales Growth (2012-2017)
  10.4.2 EMEA Immunotherapy (Biologic Therapy) Price (2012-2017)
8.5 Hormonal Therapy Sales Growth and Price
  10.5.1 EMEA Hormonal Therapy Sales Growth (2012-2017)
  10.5.2 EMEA Hormonal Therapy Price (2012-2017)
8.6 Others Sales Growth and Price
  10.6.1 EMEA Others Sales Growth (2012-2017)
  10.6.2 EMEA Others Price (2012-2017)

9 EMEA CANCER TREATMENT DRUGS MARKET SEGMENT BY APPLICATION

9.1 EMEA Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
9.2 Blood Cancer Sales Growth (2012-2017)
9.3 Breast Cancer Sales Growth (2012-2017)
9.4 Gastrointestinal Cancer Sales Growth (2012-2017)
9.5 Prostate Cancer Sales Growth (2012-2017)
9.6 Respiratory/Lung Cancer Sales Growth (2012-2017)
9.7 Other Cancers Sales Growth (2012-2017)

10 EMEA CANCER TREATMENT DRUGS MARKET FORECAST (2017-2022)

10.1 EMEA Cancer Treatment Drugs Sales, Revenue and Growth Rate (2017-2022)
10.2 Cancer Treatment Drugs Market Forecast by Regions (2017-2022)
  10.2.1 Europe Cancer Treatment Drugs Market Forecast by Regions (2017-2022)
    10.2.1.1 Germany Cancer Treatment Drugs Sales Forecast 2017-2022
    10.2.1.2 France Cancer Treatment Drugs Sales Forecast 2017-2022
    10.2.1.3 UK Cancer Treatment Drugs Sales Forecast 2017-2022
    10.2.1.4 Russia Cancer Treatment Drugs Sales Forecast 2017-2022
    10.2.1.5 Italy Cancer Treatment Drugs Sales Forecast 2017-2022
    10.2.1.6 Turkey Cancer Treatment Drugs Sales Forecast 2017-2022
  10.2.2 Middle East Market Forecast by Regions (2017-2022)
    10.2.2.1 Saudi Arabia Cancer Treatment Drugs Sales Forecast 2017-2022
    10.2.2.2 Israel Cancer Treatment Drugs Sales Forecast 2017-2022
    10.2.2.3 UAE Cancer Treatment Drugs Sales Forecast 2017-2022
    10.2.2.4 Iran Cancer Treatment Drugs Sales Forecast 2017-2022
  10.2.3 Africa Market Forecast by Regions (2017-2022)
    10.2.3.1 South Africa Cancer Treatment Drugs Sales Forecast 2017-2022
    10.2.3.2 Nigeria Cancer Treatment Drugs Sales Forecast 2017-2022
    10.2.3.3 Egypt Cancer Treatment Drugs Sales Forecast 2017-2022
    10.2.3.4 Algeria Cancer Treatment Drugs Sales Forecast 2017-2022
10.3 Cancer Treatment Drugs Market Forecast by Type (2017-2022)
10.4 Cancer Treatment Drugs Market Forecast by Application (2017-2022)

11 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

11.1 Sales Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Future Trend
11.2 Distributors, Traders and Dealers

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology
13.2 Analyst Introduction
13.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Cancer Treatment Drugs Picture
Table Product Specifications of Cancer Treatment Drugs
Figure EMEA Sales Market Share of Cancer Treatment Drugs by Types in 2016
Table Cancer Treatment Drugs Types for Major Manufacturers
Figure Chemotherapy Picture
Figure Targeted Therapy Picture
Figure Immunotherapy (Biologic Therapy) Picture
Figure Hormonal Therapy Picture
Figure Others Picture
Table Cancer Treatment Drugs Sales Market Share by Applications in 2016
Figure Blood Cancer Picture
Figure Breast Cancer Picture
Figure Gastrointestinal Cancer Picture
Figure Prostate Cancer Picture
Figure Respiratory/Lung Cancer Picture
Figure Other Cancers Picture
Figure Germany Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure France Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure UK Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Turkey Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure UAE Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Israel Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Iran Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Algeria Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Cancer Treatment Drugs Type and Applications
Table Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Cancer Treatment Drugs Type and Applications
Table Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Cancer Treatment Drugs Type and Applications
Table Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Cancer Treatment Drugs Type and Applications
Table Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Cancer Treatment Drugs Type and Applications
Table Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Cancer Treatment Drugs Type and Applications
Table Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Cancer Treatment Drugs Type and Applications
Table Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Cancer Treatment Drugs Type and Applications
Table Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Cancer Treatment Drugs Type and Applications
Table Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Cancer Treatment Drugs Type and Applications
Table AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Basic Information, Manufacturing Base and Competitors
Table Astellas Cancer Treatment Drugs Type and Applications
Table Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Cancer Treatment Drugs Type and Applications
Table Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Cancer Treatment Drugs Type and Applications
Table Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Cancer Treatment Drugs Type and Applications
Table Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Idec Basic Information, Manufacturing Base and Competitors
Table Biogen Idec Cancer Treatment Drugs Type and Applications
Table Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table Kyowa Hakko Kirin Cancer Treatment Drugs Type and Applications
Table Kyowa Hakko Kirin Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Otsuka Basic Information, Manufacturing Base and Competitors
Table Otsuka Cancer Treatment Drugs Type and Applications
Table Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Cancer Treatment Drugs Type and Applications
Table Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Cancer Treatment Drugs Type and Applications
Table Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck KGaA Basic Information, Manufacturing Base and Competitors
Table Merck KGaA Cancer Treatment Drugs Type and Applications
Table Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ipsen Basic Information, Manufacturing Base and Competitors
Table Ipsen Cancer Treatment Drugs Type and Applications
Table Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Cancer Treatment Drugs Type and Applications
Table AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Cancer Treatment Drugs Type and Applications
Table Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EMEA Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure EMEA Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure EMEA Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table EMEA Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure EMEA Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure EMEA Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Table EMEA Cancer Treatment Drugs Price by Manufacturer (2016-2017)
Figure EMEA Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure EMEA Cancer Treatment Drugs Revenue and Growth (2012-2017)
Table EMEA Cancer Treatment Drugs Sales by Regions (2012-2017)
Table EMEA Cancer Treatment Drugs Sales Market Share by Regions (2012-2017)
Figure EMEA Cancer Treatment Drugs Sales Market Share by Regions in 2012
Figure EMEA Cancer Treatment Drugs Sales Market Share by Regions in 2016
Table EMEA Cancer Treatment Drugs Revenue by Regions (2012-2017)
Table EMEA Cancer Treatment Drugs Revenue Market Share by Regions (2012-2017)
Figure EMEA Cancer Treatment Drugs Revenue Market Share by Regions in 2012
Figure EMEA Cancer Treatment Drugs Revenue Market Share by Regions in 2016
Figure Europe Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Middle East Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Africa Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Europe Cancer Treatment Drugs Revenue and Growth (2012-2017)
Table Europe Cancer Treatment Drugs Sales by Countries (2012-2017)
Table Europe Cancer Treatment Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Cancer Treatment Drugs Sales Market Share by Countries in 2012
Figure Europe Cancer Treatment Drugs Sales Market Share by Countries in 2016
Table Europe Cancer Treatment Drugs Revenue by Countries (2012-2017)
Table Europe Cancer Treatment Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Cancer Treatment Drugs Revenue Market Share by Countries in 2012
Figure Europe Cancer Treatment Drugs Revenue Market Share by Countries in 2016
Figure Germany Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure France Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure UK Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Russia Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Italy Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Turkey Cancer Treatment Drugs Sales and Growth (2012-2017)
Table Europe Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure Europe Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure Europe Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table Europe Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure Europe Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure Europe Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Table Europe Cancer Treatment Drugs Sales by Type (2012-2017)
Table Europe Cancer Treatment Drugs Sales Share by Type (2012-2017)
Table Europe Cancer Treatment Drugs Sales by Application (2012-2017)
Table Europe Cancer Treatment Drugs Sales Share by Application (2012-2017)
Figure Middle East Cancer Treatment Drugs Revenue and Growth (2012-2017)
Table Middle East Cancer Treatment Drugs Sales by Countries (2012-2017)
Table Middle East Cancer Treatment Drugs Sales Market Share by Countries (2012-2017)
Figure Middle East Cancer Treatment Drugs Sales Market Share by Countries in 2012
Figure Middle East Cancer Treatment Drugs Sales Market Share by Countries in 2016
Table Middle East Cancer Treatment Drugs Revenue by Countries (2012-2017)
Table Middle East Cancer Treatment Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Cancer Treatment Drugs Revenue Market Share by Countries in 2012
Figure Middle East Cancer Treatment Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Israel Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure UAE Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Iran Cancer Treatment Drugs Sales and Growth (2012-2017)
Table Middle East Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure Middle East Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure Middle East Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table Middle East Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure Middle East Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure Middle East Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Table Middle East Cancer Treatment Drugs Sales by Type (2012-2017)
Table Middle East Cancer Treatment Drugs Sales Share by Type (2012-2017)
Table Middle East Cancer Treatment Drugs Sales by Application (2012-2017)
Table Middle East Cancer Treatment Drugs Sales Share by Application (2012-2017)
Figure Africa Cancer Treatment Drugs Revenue and Growth (2012-2017)
Table Africa Cancer Treatment Drugs Sales by Countries (2012-2017)
Table Africa Cancer Treatment Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Cancer Treatment Drugs Sales Market Share by Countries in 2012
Figure Africa Cancer Treatment Drugs Sales Market Share by Countries in 2016
Table Africa Cancer Treatment Drugs Revenue by Countries (2012-2017)
Table Africa Cancer Treatment Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Cancer Treatment Drugs Revenue Market Share by Countries in 2012
Figure Africa Cancer Treatment Drugs Revenue Market Share by Countries in 2016
Figure South Africa Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Nigeria Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Egypt Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Algeria Cancer Treatment Drugs Sales and Growth (2012-2017)
Table Middle East Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure Middle East Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure Middle East Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table Middle East Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure Middle East Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure Middle East Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Table Middle East Cancer Treatment Drugs Sales by Type (2012-2017)
Table Middle East Cancer Treatment Drugs Sales Share by Type (2012-2017)
Table Middle East Cancer Treatment Drugs Sales by Application (2012-2017)
Table Middle East Cancer Treatment Drugs Sales Share by Application (2012-2017)
Table EMEA Cancer Treatment Drugs Sales by Type (2012-2017)
Table EMEA Cancer Treatment Drugs Sales Share by Type (2012-2017)
Table EMEA Cancer Treatment Drugs Revenue by Type (2012-2017)
Table EMEA Cancer Treatment Drugs Revenue Share by Type (2012-2017)
Figure EMEA Chemotherapy Sales Growth (2012-2017)
Figure EMEA Chemotherapy Price (2012-2017)
Figure EMEA Targeted Therapy Sales Growth (2012-2017)
Figure EMEA Targeted Therapy Price (2012-2017)
Figure EMEA Immunotherapy (Biologic Therapy) Sales Growth (2012-2017)
Figure EMEA Immunotherapy (Biologic Therapy) Price (2012-2017)
Figure EMEA Hormonal Therapy Sales Growth (2012-2017)
Figure EMEA Hormonal Therapy Price (2012-2017)
Figure EMEA Others Sales Growth (2012-2017)
Figure EMEA Others Price (2012-2017)
Table EMEA Cancer Treatment Drugs Sales by Application (2012-2017)
Table EMEA Cancer Treatment Drugs Sales Share by Application (2012-2017)
Figure EMEA Blood Cancer Sales Growth (2012-2017)
Figure EMEA Breast Cancer Sales Growth (2012-2017)
Figure EMEA Gastrointestinal Cancer Sales Growth (2012-2017)
Figure EMEA Prostate Cancer Sales Growth (2012-2017)
Figure EMEA Respiratory/Lung Cancer Sales Growth (2012-2017)
Figure EMEA Other Cancers Sales Growth (2012-2017)
Figure EMEA Cancer Treatment Drugs Sales, Revenue and Growth Rate (2017-2022)
Table EMEA Cancer Treatment Drugs Sales Forecast by Regions (2017-2022)
Table EMEA Cancer Treatment Drugs Market Share Forecast by Regions (2017-2022)
Table Europe Cancer Treatment Drugs Sales Forecast by Regions (2017-2022)
Figure Germany Cancer Treatment Drugs Sales Forecast 2017-2022
Figure France Cancer Treatment Drugs Sales Forecast 2017-2022
Figure UK Cancer Treatment Drugs Sales Forecast 2017-2022
Figure Russia Cancer Treatment Drugs Sales Forecast 2017-2022
Figure Italy Cancer Treatment Drugs Sales Forecast 2017-2022
Figure Turkey Cancer Treatment Drugs Sales Forecast 2017-2022
Table Middle East Sales Forecast by Regions (2017-2022)
Figure Saudi Arabia Cancer Treatment Drugs Sales Forecast 2017-2022
Figure Israel Cancer Treatment Drugs Sales Forecast 2017-2022
Figure UAE Cancer Treatment Drugs Sales Forecast 2017-2022
Figure Iran Cancer Treatment Drugs Sales Forecast 2017-2022
Table Africa Sales Forecast by Regions (2017-2022)
Figure South Africa Cancer Treatment Drugs Sales Forecast 2017-2022
Figure Nigeria Cancer Treatment Drugs Sales Forecast 2017-2022
Figure Egypt Cancer Treatment Drugs Sales Forecast 2017-2022
Figure Algeria Cancer Treatment Drugs Sales Forecast 2017-2022
Table EMEA Cancer Treatment Drugs Sales Forecast by Type (2017-2022)
Table EMEA Cancer Treatment Drugs Market Share Forecast by Type (2017-2022)
Table EMEA Cancer Treatment Drugs Sales Forecast by Application (2017-2022)
Table EMEA Cancer Treatment Drugs Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List